NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year […]
